Dominant suppression of inflammation by glycan-hydrolyzed IgG
about
The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid ArthritisRole of siglecs and related glycan-binding proteins in immune responses and immunoregulationTherapeutic potential of deglycosylated antibodies.Profiling IgG N-glycans as potential biomarker of chronological and biological ages: A community-based study in a Han Chinese populationIntravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.Targeting B cells and autoantibodies in the therapy of autoimmune diseases.Fragments of bacterial endoglycosidase s and immunoglobulin g reveal subdomains of each that contribute to deglycosylation.
P2860
Q28395318-7926A3A5-0462-4E9F-A53A-46A1303456FDQ35164415-2645054F-EAE1-4FEB-BD90-77B5E3AB2A16Q36950457-84DF4D71-93A9-4CBD-803F-06920F3A2304Q37116784-CA23CA0A-584C-4D68-A8FA-C12D04EFEF38Q38133405-7FD6E2C6-49AF-499B-B959-7BCA172D60CFQ38207937-42ED527A-BE13-4619-A767-41357165667CQ39661732-0CEEC394-EF84-4C7D-9485-A36DE75BD188
P2860
Dominant suppression of inflammation by glycan-hydrolyzed IgG
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dominant suppression of inflammation by glycan-hydrolyzed IgG
@en
type
label
Dominant suppression of inflammation by glycan-hydrolyzed IgG
@en
prefLabel
Dominant suppression of inflammation by glycan-hydrolyzed IgG
@en
P2093
P2860
P50
P356
P1476
Dominant suppression of inflammation by glycan-hydrolyzed IgG
@en
P2093
Allyson M Croxford
Merrill J Rowley
Rikard Holmdahl
Roman A Zubarev
Susanna L Lundström
P2860
P304
10252-10257
P356
10.1073/PNAS.1301480110
P407
P577
2013-05-13T00:00:00Z